NCT00242489View on ClinicalTrials.gov

Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

PHASE2CompletedINTERVENTIONAL
Enrollment

1,167

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

February 28, 1999

Study Completion Date

July 31, 2002

Conditions
Osteoarthritis
Interventions
DRUG

MK0663, etoricoxib / Duration of Treatment: Part I (6 weeks), Part II (8 weeks)

DRUG

Placebo;Diclofenac 50mg(tid)/Duration of Treatment: Part I (Placebo) 6 weeks;Part II (Diclofenac) 8 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00242489 - Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007) | Biotech Hunter | Biotech Hunter